Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

The objective of this work is to analyze the survival of infliximab, etanercept and adalimumab in patients who have switched among tumor necrosis factor (TNF) antagonists for the treatment of chronic arthritis. BIOBADASER is a national registry of patients with different forms of chronic arthritis w...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Reino, Juan J, Carmona, Loreto
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526564/
https://www.ncbi.nlm.nih.gov/pubmed/16507128
http://dx.doi.org/10.1186/ar1881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526564/
https://www.ncbi.nlm.nih.gov/pubmed/16507128
http://dx.doi.org/10.1186/ar1881

Ejemplares similares